Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 21 | 2024 | 7702 | 1.070 |
Why?
|
| Skull Base Neoplasms | 1 | 2022 | 314 | 0.670 |
Why?
|
| Leukoencephalopathies | 2 | 2018 | 63 | 0.620 |
Why?
|
| Hydrocephalus | 3 | 2024 | 217 | 0.520 |
Why?
|
| Neck Injuries | 1 | 2014 | 32 | 0.470 |
Why?
|
| Societies, Medical | 6 | 2022 | 1335 | 0.460 |
Why?
|
| Contrast Media | 6 | 2022 | 1472 | 0.460 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 122 | 0.460 |
Why?
|
| Angiography | 1 | 2014 | 360 | 0.430 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2014 | 176 | 0.430 |
Why?
|
| White Matter | 1 | 2015 | 195 | 0.430 |
Why?
|
| Brain Stem | 2 | 2022 | 175 | 0.420 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2015 | 422 | 0.420 |
Why?
|
| Vestibular Nerve | 1 | 2011 | 6 | 0.410 |
Why?
|
| Pons | 1 | 2011 | 51 | 0.400 |
Why?
|
| Neuroimaging | 7 | 2023 | 403 | 0.390 |
Why?
|
| Child | 28 | 2024 | 29154 | 0.380 |
Why?
|
| Nervous System Malformations | 1 | 2011 | 133 | 0.360 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 144 | 0.360 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2024 | 43 | 0.350 |
Why?
|
| Brain | 5 | 2023 | 4113 | 0.340 |
Why?
|
| Craniocerebral Trauma | 2 | 2020 | 130 | 0.330 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 1648 | 0.330 |
Why?
|
| Sinusitis | 2 | 2020 | 131 | 0.320 |
Why?
|
| Epilepsy | 1 | 2015 | 883 | 0.310 |
Why?
|
| Evidence-Based Medicine | 6 | 2022 | 1085 | 0.290 |
Why?
|
| Pediatrics | 1 | 2015 | 1141 | 0.280 |
Why?
|
| Demyelinating Diseases | 2 | 2018 | 77 | 0.270 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 1237 | 0.260 |
Why?
|
| Inflammation | 1 | 2015 | 2522 | 0.250 |
Why?
|
| Tuberculosis, Spinal | 1 | 2023 | 12 | 0.240 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2023 | 11 | 0.240 |
Why?
|
| Skull | 2 | 2022 | 231 | 0.240 |
Why?
|
| Actinomycetaceae | 1 | 2023 | 6 | 0.240 |
Why?
|
| Actinomycosis | 1 | 2023 | 7 | 0.240 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2003 | 12 | 0.240 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2023 | 30 | 0.230 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2003 | 23 | 0.230 |
Why?
|
| Empyema | 1 | 2023 | 28 | 0.230 |
Why?
|
| Infant | 10 | 2022 | 13310 | 0.230 |
Why?
|
| Basal Ganglia | 1 | 2003 | 64 | 0.230 |
Why?
|
| Globus Pallidus | 1 | 2003 | 71 | 0.230 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 1697 | 0.220 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2023 | 26 | 0.220 |
Why?
|
| Diagnosis, Differential | 8 | 2022 | 4744 | 0.220 |
Why?
|
| Surface Plasmon Resonance | 1 | 2022 | 105 | 0.220 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2023 | 142 | 0.210 |
Why?
|
| Fourth Ventricle | 1 | 2022 | 51 | 0.210 |
Why?
|
| Tinnitus | 1 | 2022 | 38 | 0.210 |
Why?
|
| Survivorship | 1 | 2022 | 109 | 0.210 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 72 | 0.200 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 38 | 0.200 |
Why?
|
| Humans | 42 | 2024 | 261506 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2022 | 7551 | 0.200 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 303 | 0.200 |
Why?
|
| Malignant Atrophic Papulosis | 1 | 2020 | 3 | 0.190 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 341 | 0.190 |
Why?
|
| Scalp | 1 | 2021 | 156 | 0.180 |
Why?
|
| Mitochondrial Diseases | 1 | 2022 | 137 | 0.180 |
Why?
|
| Hematoma, Subdural | 1 | 2019 | 28 | 0.180 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 61 | 0.180 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 52 | 0.180 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 280 | 0.180 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 142 | 0.170 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 70 | 0.170 |
Why?
|
| Spinal Injuries | 1 | 2019 | 32 | 0.170 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2018 | 11 | 0.170 |
Why?
|
| Meningitis, Viral | 1 | 2018 | 13 | 0.170 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2018 | 13 | 0.170 |
Why?
|
| Myelitis | 1 | 2018 | 26 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 446 | 0.160 |
Why?
|
| Child, Preschool | 10 | 2022 | 16273 | 0.160 |
Why?
|
| Cochlea | 1 | 2018 | 102 | 0.160 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 63 | 0.160 |
Why?
|
| Polyneuropathies | 1 | 2018 | 28 | 0.160 |
Why?
|
| Temporal Bone | 2 | 2018 | 102 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2023 | 341 | 0.150 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 1162 | 0.150 |
Why?
|
| Brain Neoplasms | 3 | 2022 | 4849 | 0.150 |
Why?
|
| West Nile virus | 1 | 2018 | 128 | 0.150 |
Why?
|
| Child Abuse | 1 | 2019 | 193 | 0.150 |
Why?
|
| Brain Injuries | 1 | 2003 | 787 | 0.150 |
Why?
|
| West Nile Fever | 1 | 2018 | 151 | 0.140 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2016 | 15 | 0.140 |
Why?
|
| Retrospective Studies | 12 | 2024 | 37905 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 641 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 500 | 0.130 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2014 | 6 | 0.130 |
Why?
|
| Hearing Aids | 1 | 2014 | 14 | 0.130 |
Why?
|
| Transverse Sinuses | 1 | 2014 | 1 | 0.130 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2014 | 2 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.130 |
Why?
|
| Vertebral Artery | 1 | 2014 | 42 | 0.120 |
Why?
|
| Infant, Newborn | 5 | 2022 | 8223 | 0.120 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 1005 | 0.120 |
Why?
|
| Medical Oncology | 1 | 2022 | 1423 | 0.120 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2014 | 104 | 0.120 |
Why?
|
| Glasgow Coma Scale | 1 | 2014 | 215 | 0.120 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 590 | 0.120 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2013 | 18 | 0.120 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 116 | 0.120 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2013 | 42 | 0.110 |
Why?
|
| Male | 17 | 2022 | 123000 | 0.110 |
Why?
|
| Ipilimumab | 1 | 2018 | 710 | 0.110 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 103 | 0.110 |
Why?
|
| Female | 18 | 2024 | 141928 | 0.110 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 216 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.110 |
Why?
|
| Proton Therapy | 1 | 2022 | 1577 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.100 |
Why?
|
| Audiometry | 1 | 2011 | 24 | 0.100 |
Why?
|
| Neck | 1 | 2014 | 383 | 0.100 |
Why?
|
| Sampling Studies | 1 | 2011 | 170 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.100 |
Why?
|
| Ataxia | 2 | 2022 | 176 | 0.100 |
Why?
|
| Cochlear Implantation | 1 | 2011 | 45 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 925 | 0.090 |
Why?
|
| Organometallic Compounds | 2 | 2013 | 191 | 0.080 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 1249 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2011 | 351 | 0.080 |
Why?
|
| Syndrome | 1 | 2011 | 1351 | 0.080 |
Why?
|
| Adolescent | 6 | 2020 | 31252 | 0.080 |
Why?
|
| Risk Factors | 2 | 2015 | 17523 | 0.070 |
Why?
|
| Electroencephalography | 1 | 2011 | 898 | 0.070 |
Why?
|
| Survivors | 2 | 2022 | 1031 | 0.070 |
Why?
|
| Seizures | 2 | 2023 | 989 | 0.070 |
Why?
|
| United States | 5 | 2021 | 15433 | 0.070 |
Why?
|
| Cytokines | 1 | 2015 | 2809 | 0.070 |
Why?
|
| Meninges | 1 | 2023 | 47 | 0.060 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2003 | 3 | 0.060 |
Why?
|
| Prognosis | 3 | 2024 | 21713 | 0.060 |
Why?
|
| Spin Labels | 1 | 2023 | 76 | 0.060 |
Why?
|
| Biomarkers | 1 | 2015 | 5047 | 0.060 |
Why?
|
| Joint Diseases | 1 | 2003 | 71 | 0.060 |
Why?
|
| Heterocyclic Compounds | 1 | 2003 | 119 | 0.060 |
Why?
|
| Streptococcus gallolyticus | 1 | 2022 | 3 | 0.060 |
Why?
|
| Gadolinium DTPA | 1 | 2003 | 172 | 0.060 |
Why?
|
| Skull Base | 1 | 2024 | 199 | 0.060 |
Why?
|
| Gadolinium | 1 | 2003 | 164 | 0.050 |
Why?
|
| Streptococcus | 1 | 2022 | 68 | 0.050 |
Why?
|
| Verbal Learning | 1 | 2022 | 84 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2022 | 88 | 0.050 |
Why?
|
| Penicillins | 1 | 2022 | 143 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2020 | 61 | 0.050 |
Why?
|
| Melanoma | 1 | 2018 | 5317 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 259 | 0.050 |
Why?
|
| Biological Factors | 1 | 2020 | 45 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2003 | 349 | 0.050 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 58 | 0.050 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 64 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2015 | 12873 | 0.040 |
Why?
|
| Workplace | 1 | 2020 | 76 | 0.040 |
Why?
|
| Protons | 1 | 2022 | 473 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2023 | 690 | 0.040 |
Why?
|
| Cranial Nerve Diseases | 1 | 2020 | 73 | 0.040 |
Why?
|
| Headache | 1 | 2020 | 163 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2020 | 149 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 485 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 98 | 0.040 |
Why?
|
| Cerebral Aqueduct | 1 | 2018 | 8 | 0.040 |
Why?
|
| Cerebellum | 1 | 2022 | 449 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 1178 | 0.040 |
Why?
|
| Pregnancy | 2 | 2024 | 7573 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 143 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 829 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 323 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2020 | 436 | 0.040 |
Why?
|
| Family | 1 | 2021 | 736 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 968 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 966 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 534 | 0.030 |
Why?
|
| Nitriles | 1 | 2020 | 906 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 4971 | 0.030 |
Why?
|
| Suture Anchors | 1 | 2014 | 7 | 0.030 |
Why?
|
| Mitochondria | 1 | 2022 | 1282 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 2315 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 1259 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 601 | 0.030 |
Why?
|
| Optic Disk | 1 | 2014 | 54 | 0.030 |
Why?
|
| Meglumine | 1 | 2013 | 20 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 441 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 409 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 310 | 0.030 |
Why?
|
| Optic Nerve | 1 | 2014 | 133 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 2013 | 141 | 0.030 |
Why?
|
| Adult | 4 | 2023 | 77950 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 671 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2014 | 749 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 703 | 0.030 |
Why?
|
| Texas | 1 | 2022 | 6311 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 1471 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 3251 | 0.020 |
Why?
|
| Disease Progression | 1 | 2020 | 6682 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2020 | 3518 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 3260 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9244 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 6100 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 4892 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 6009 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 86204 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 29902 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 32848 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 70117 | 0.000 |
Why?
|